Measles is a disease that was reported as eliminated in the United States in 2000, according to the Centers for Disease Control. Most babies born in the US receive an immunization shot for the measles in a vaccine that generally covers measles, mumps, and rubella (MMR). With that said, it’s a bit of a surprise that there has been a measles outbreak in the United States reported by many news outlets. The outbreak hasn’t been as large or as deadly as the Ebola outbreak, but it is concerning.
I was curious who owns the Measles.com domain name, and it appears to be owned by a healthcare company. The domain name is currently parked with pay per click advertising links, and you’ll see a banner across the top of the landing page announcing that Measles.com is for sale. After a bit of searching, I learned that Measles.com is being brokered exclusively by Right of the Dot.
I reached out to Right of the Dot co-founder Monte Cahn, and he confirmed that the domain name is up for sale, and “the bidding starts at $50,000,” he said. Cahn described the opportunity as “a steal for a pharma or medical company in the space.”
I think this domain name would make sense for a company that either produces the measles vaccinations or offers a treatment for people who are infected with measles. Apparently, there are quite a few parties that would like to buy Measles.com. Cahn told me that “this domain has had a lot of interest obviously due to all the outbreak.”
I wouldn’t buy Measles.com for my company because I don’t think it would be worth the negative publicity associated with owning it as a domain investor (see my article about the Ebola.com sale for more details about that!) In addition, this domain name would only really increase in value if the outbreak grows, and I have no interest in hoping this disease spreads so that an investment would appreciate in value. I wouldn’t judge someone else, but it’s just not for me.
Measles.com represents a good opportunity for a company that is involved in the vaccination or treatment for measles. If Measles.com sells, I will share the details with you.